KR0178469B1 - 흥분성 아미노산 길항제 - Google Patents

흥분성 아미노산 길항제 Download PDF

Info

Publication number
KR0178469B1
KR0178469B1 KR1019930700112A KR930700112A KR0178469B1 KR 0178469 B1 KR0178469 B1 KR 0178469B1 KR 1019930700112 A KR1019930700112 A KR 1019930700112A KR 930700112 A KR930700112 A KR 930700112A KR 0178469 B1 KR0178469 B1 KR 0178469B1
Authority
KR
South Korea
Prior art keywords
compound
alkyl
phenyl
pharmaceutically acceptable
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019930700112A
Other languages
English (en)
Korean (ko)
Inventor
프란세스코 지 살리투로
브루스 엠. 바론
Original Assignee
메이나드 알. 존슨
메렐 다우 파마슈티칼스 인크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 메이나드 알. 존슨, 메렐 다우 파마슈티칼스 인크 filed Critical 메이나드 알. 존슨
Application granted granted Critical
Publication of KR0178469B1 publication Critical patent/KR0178469B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019930700112A 1990-07-16 1991-06-17 흥분성 아미노산 길항제 Expired - Fee Related KR0178469B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55605790A 1990-07-16 1990-07-16
US556,057 1990-07-16

Publications (1)

Publication Number Publication Date
KR0178469B1 true KR0178469B1 (ko) 1999-03-20

Family

ID=24219725

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930700112A Expired - Fee Related KR0178469B1 (ko) 1990-07-16 1991-06-17 흥분성 아미노산 길항제

Country Status (15)

Country Link
US (1) US5106847A (enExample)
EP (1) EP0539503B1 (enExample)
JP (1) JP3058688B2 (enExample)
KR (1) KR0178469B1 (enExample)
AT (1) ATE136295T1 (enExample)
AU (1) AU646686B2 (enExample)
CA (1) CA2087091C (enExample)
DE (1) DE69118539T2 (enExample)
DK (1) DK0539503T3 (enExample)
ES (1) ES2088011T3 (enExample)
FI (1) FI98455C (enExample)
GR (1) GR3019689T3 (enExample)
HU (1) HU216787B (enExample)
NO (1) NO179249C (enExample)
WO (1) WO1992001670A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189054A (en) * 1990-11-02 1993-02-23 Merrell Dow Pharmaceuticals Inc. 3-amidoindolyl derivatives and pharmaceutical compositions thereof
US5318985A (en) * 1991-12-20 1994-06-07 Merrell Dow Pharmaceuticals Inc. Potentiation of NMDA antagonists
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
USRE39300E1 (en) 1993-01-28 2006-09-19 Virginia Commonwealth University Medical College Of Virginia Inhibiting the development of tolerance to and/or dependence on an addictive substance
US5519048A (en) * 1993-05-27 1996-05-21 Merrell Pharmaceuticals Inc. 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
TW280819B (enExample) * 1993-11-17 1996-07-11 Sumitomo Pharma
US5783575A (en) * 1994-03-14 1998-07-21 Novo Nordisk A/S Antagonists, their preparation and use
US5696148A (en) * 1994-03-14 1997-12-09 Novo Nordisk A/S Indole compounds and their use in treating diseases of the central nervous system
US5563157B1 (en) 1994-10-31 1999-02-02 Hoecst Marion Roussel Inc Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition
JPH11509847A (ja) * 1995-07-31 1999-08-31 ノボ ノルディスク アクティーゼルスカブ ヘテロ環式化合物、それらの調製及び使用
WO1998014427A1 (en) * 1996-09-30 1998-04-09 Hoechst Marion Roussel, Inc. Nmda (n-methyl-d-aspartate) antagonists
DE69826881T2 (de) 1997-03-14 2005-12-01 Smithkline Beecham Corp. Neue indolcarboxamide, pharmazeutische zusammensetzungen und methoden zur hemmung von calpain
US5922752A (en) * 1997-06-11 1999-07-13 Hoechst Marion Roussell, Inc. NMDA (n-methyl-d-aspartate) antagonists
JP2005506292A (ja) * 2001-03-08 2005-03-03 エモリー　ユニバーシティ ｐＨに依存するＮＭＤＡレセプターアンタゴニスト
WO2003039540A2 (en) * 2001-11-09 2003-05-15 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
AU2008272964A1 (en) * 2007-06-29 2009-01-08 Emory University NMDA receptor antagonists for neuroprotection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
JPH0347123A (ja) * 1989-05-05 1991-02-28 G D Searle & Co インドール―２―カルボキシレート化合物類を含有するｃｎｓ疾患治療用組成物
CA2091257A1 (en) * 1990-09-10 1992-03-11 Fu-Chih Huang Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonists activity
WO1993005020A1 (en) * 1991-09-06 1993-03-18 Merck & Co., Inc. Indoles as inhibitors of hiv reverse transcriptase

Also Published As

Publication number Publication date
NO179249C (no) 1996-09-04
NO930035D0 (no) 1993-01-07
DE69118539T2 (de) 1996-09-19
FI930150A0 (fi) 1993-01-14
US5106847A (en) 1992-04-21
DE69118539D1 (de) 1996-05-09
HU9300100D0 (en) 1993-04-28
HUT67237A (en) 1995-03-28
FI930150L (fi) 1993-01-14
GR3019689T3 (en) 1996-07-31
FI98455C (fi) 1997-06-25
WO1992001670A1 (en) 1992-02-06
CA2087091C (en) 2001-09-11
CA2087091A1 (en) 1992-01-17
ES2088011T3 (es) 1996-08-01
FI98455B (fi) 1997-03-14
DK0539503T3 (da) 1996-05-13
EP0539503B1 (en) 1996-04-03
NO179249B (no) 1996-05-28
HU216787B (hu) 1999-08-30
JP3058688B2 (ja) 2000-07-04
EP0539503A1 (en) 1993-05-05
ATE136295T1 (de) 1996-04-15
NO930035L (no) 1993-01-07
AU8290891A (en) 1992-02-18
AU646686B2 (en) 1994-03-03
EP0539503A4 (enExample) 1994-03-23
JPH05508857A (ja) 1993-12-09

Similar Documents

Publication Publication Date Title
KR0178469B1 (ko) 흥분성 아미노산 길항제
KR0164434B1 (ko) 흥분성 아미노산 길항제
JP2716099B2 (ja) １，２，３，３ａ，８，８ａ−ヘキサヒドロ−３ａ，８（および１，３ａ，８）−ジ（およびトリ）メチルピロロ〔２，３−ｂ〕インドールおよびそれらの製造法
DE69524114T2 (de) Naphthyridinonderivate
JP3168565B2 (ja) ３−アミドインドリル誘導体類
JPH0739346B2 (ja) 抗ヒスタミン／抗アレルギー剤
FR2690919A1 (fr) Dérivés de l'indole.
KR0169107B1 (ko) 흥분성 아미노산 길항제
JP3006881B2 (ja) ３―インドリルチオアセテート誘導体類
DE69629341T2 (de) Pyrrolocarbazolderivate
EP1003724B1 (de) Substituierte-chinolin-derivate mit antiviraler wirkung
CA2039937A1 (fr) Derives du 3-aminochromane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE69633289T2 (de) 4-acylamino(halogen)alkyl-chinolin derivate, deren herstellung und deren verwendung als melatonin-agonisten
JPH037280A (ja) 新規ベンゾチオピラニルアミン
MC1562A1 (fr) Phenothiazines,leur procede de preparation et produits en contenant
US5112821A (en) Excitatory amino acid antagonists which are certain thienopyridives
WO2001014385A1 (en) Dihydrobenzofuran derivatives, process for the preparation thereof and agents
JPH0826024B2 (ja) α−オキソピロロ〔２，３−ｂ〕インドール酢酸、エステル、アミドおよび関連する類似体
AU637848B2 (en) Pyridine-2,4- and 2,5-dicarboxamides, a process for the preparation thereof, and the use thereof
JPH11509188A (ja) プロドラッグ６−ｎ−（ｌ−ａｌａ−ｌ−ａｌａ）トロバフロキサシンの多形体
JPH0425268B2 (enExample)
JPH0733660A (ja) 脂質代謝改善剤
CZ20002257A3 (cs) Karboxysubstituované chromanové deriváty, které lze použít jako beta-3-adrenoreceptorové agonisty
CS235350B2 (cs) Způsob výroby nových aminosloučenin
CS209950B2 (en) Method of making the new 4- amino-6,7-dialcoxy-2-piperazinochinazoline derivatives

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20021113

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20031124

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20031124

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000